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We have shown previously that the skeletal muscle ryanodine receptor mRNA of - 16,000 nucleotides codes 5,037 amino acid residues constituting 
the calcium release channel in skeletal muscle. In this study, RNA blot hybridization analysis shows that the brain contains an RNA species with 
an estimated size of -2,400 nucleotides hybridizable with the 3’-terminal region of the skeletal muscle ryanodine receptor cDNA. cDNA cloning 
and genome analysis indicated that two transcripts differing in their start sites are produced from the skeletal muscle ryanodine receptor gene in 
a tissue-specific fashion, and that the mRNA in brain may code the carboxyl-terminal region of the ryanodine receptor molecule. cDNA expression 
experiments suggested that the ATG triplet encoding Met 4382 of the skeletal muscle ryanodine receptor can function as a translation initiation codon, 
and that the expressed protein composed of the carboxy terminal 656 amino acid residues of the receptor is located on the endoplasmic reticulum 
membrane. 
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1. INTRODUCTION 
The ryanodine receptor functions as a calcium-in- 
duced calcium release channel and takes part in Ca2’ 
release from intracellular stores [ 1,2]. Skeletal muscle 
sarcoplasmic reticulum (SR) provides the richest source 
of the ryanodine receptor. The purified receptor was 
shown to form a homo-tetrameric complex and was 
identified with the ‘foot’ structure which spans the gap 
between the SR and transverse tubule membranes [2]. 
Cloning and sequence analysis of cDNA have revealed 
that the rabbit skeletal muscle ryanodine receptor is 
composed of 5037 amino acid residues, comprising the 
carboxy-terminal channel region which has four puta- 
tive transmembrane segments, and the remaining por- 
tion which apparently constitutes the ‘foot’ structure [3]. 
Previous observations indicated that the ryanodine re- 
ceptor expressed from the cDNA is localized to calcium 
pools of the endoplasmic reticulum (ER) and functions 
as a calcium release channel in Chinese hamster ovary 
(CHO) cells [4,5]. 
three types of the ryanodine receptor in mammalian 
tissues, the skeletal muscle, the cardiac, and the brain 
ryanodine receptor [3,9-121. Our recent studies have 
shown that the brain contains the cardiac and the brain 
ryanodine receptor types, and the distribution of the 
receptors in rabbit brain has also been investigated by 
RNA blot hybridization analysis [12]. This report deals 
with a brain-specific RNA species derived from the 3’- 
region of the skeletal muscle ryanodine receptor gene. 
2. MATERIALS AND METHODS 
2.1. RNA blot hybridization analysis 
Calcium-induced calcium release has been observed 
in a variety of cell types, including neurons [b8]. cDNA 
cloning studies have previously shown that there are 
Total RNA was extracted from rabbit tissues by the guanidinium 
thiocyanate/cesium chloride method [13] and poly(A)’ RNA was puri- 
fied using oligo(dT)-cellulose [14]. RNA samples were denatured with 
glyoxal [15], electrophoresed on 1% agarose gels and transferred to 
Biodyne nylon membranes (Pall). The probes used were the 
SrnaI( 13290)lSmaI( 15 18 1) fragment from the skeletal muscle ryan- 
odine receptor cDNA clone pRR616 [3]; restriction endonuclease sites 
are identified by number (in parentheses) indicating the 5’-terminal 
nucleotide generated by cleavage. The probes were labelled with [a- 
‘*P]dCTP as in [16]. The hybridization and washing condition were the 
same as in [17]. Autoradiography was performed at -80°C with an 
intensifying screen. An RNA ladder (Bethesda Research Laborato- 
ries) or Hind111 cleavage products of/z phage DNA were used as size 
markers. 
Correspondence address: H. Takeshima, International Institute for 
Advanced Studies, Shimadzu N-80, 1 Nishinokyo-Kuwabara-cho, 
Nakagyo-ku, Kyoto 604, Japan. Fax: (81) (75) 811 8186. 
Abbreviations: SR, sarcoplasmic reticulum; ER, endoplasmic reticu- 
lum; CHO cell, Chinese hamster ovary cell. 
2.2. DNA cloning 
Oligo(dT)-primed rabbit brain cDNA libraries [10,12] were 
screened with the StnaI( 13290)/SmaI( 15 181) fragment derived from 
clone pRR616 [3] to yield 12 clones. The cDNA inserts of these clones 
were subcloned into pBluescript (Stratagene) and analysed with re- 
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striction endonucleases (digestion with R.saI and with BunI). All clones 
yielded fragments common to those derived from the 3’-terminal re- 
gion of the skeletal muscle ryanodine receptor cDNA. Among the 
cDNA clones, 8 clones were further analysed as shown below. The 
clone ;1BRR2 carries nucleotides 13899 to 15230 and the poly(dA) 
tract (nucleotide residues are numbered as in [3]); 1BRR6 (13583- 
15230 and the poly(dA) tract); jlBRR4 (13549-15230 and the poly(dA) 
tract); 1BRR3 (13481-15230 and the poly(dA) tract); ilBRR319 
(1345615230 and the poly(dA) tract); aBRR313 (13347-15230 and 
the poly(dA) tract); 1BRR308 (1310415230 and the poly(dA) tract); 
aBRR3 10 (13082-l 5230 and the poly(dA) tract). The cDNA sequence 
of the I1BRR2 was determined [18] and both ends of the cDNAs 
carried by the other 7 clones were sequenced (- 250 nucleotides). 
These data showed that the brain-cDNA sequence is identical to that 
of the skeletal muscle ryanodine receptor cDNA corresponding to 
residues 13082 to 15230. Some clones (aBRR3, WRR4 and ;1BRR3 19) 
include differences in the 3’-noncoding sequence as follows: GCCC for 
ACT at 15175-15177 and GTC for AC at 15212-15213. 
A synthetic primer complementary to nucleotide residues 13315- 
13335, prepared using an automatic DNA synthesizer (Applied Bio- 
systems), was elongated by the procedures described previously [3] 
using rabbit brain poly(A)’ RNA. The resulting clones were selected 
with the 0.21 kbp EcoRI (vector)/SmaI (13290) fragment from 
1BRR310 to yield 11 positive clones including /ZBRR401 (12931- 
13335), aBRR406 (13060-13335), aBRR410 (13058-13335) 
ilBRR413 (13031-13335) and aBRR417 (12922-13335). Sequence 
analysis of these clones showed that they carry partial sequences of 
the skeletal muscle ryanodine receptor cDNA. 
A rabbit genomic DNA library [19] was screened with the 0.21-kbp 
PsrI (vector)/SphI (13146) fragment from I1BRR401 to yield 
jlBRRG31. The - 1.8-kbp PsrI fragment and the - 3.0-kbp SmaI 
fragment from /ZBRRG3 1 were subcloned into pUC 18 or pBluescript 
to analyse the sequence. The genomic sequences corresponding to 
residues 12628 to 13434, 13435 to 13505 and 13506 to 13656 of the 
skeletal muscle ryanodine receptor cDNA are uninterrupted. Their 
sequences at the exon-intron boundaries are consistent with the GT- 
AC rule. The nucleotide differences observed between cDNA and 
genomic DNA clones are as follows: A (cDNA clone) or G (genomic) 
at 13446 and C (cDNA) or T (genomic) at 13487. Both of the substi- 
tutions cause no differences in amino acid sequence. 
2.3. cDNA expression in CHO cells 
The 2.1-kbpBstEI1 (13122)lHincII (vector) fragment from pRR616 
[3] was blunted and then subcloned into the H&II site of pSP 64 to 
yield pRRSl2; a one-base-pair deletion from the HincII site ligated to 
the 5’-terminal BsrEII site of the cDNA occurred during the construc- 
tion. The 2.1-kbp Hind111 fragment from pRRS12 was cloned into the 
Hind111 site of pKNH [20,21] to yield an expression plasmid pRRSl3. 
In this plasmid the cDNA insert was positioned downstream of and 
in the same orientation as the SV 40 promoter. If the Met4382 would 
function as the initiation methionine, the mRNA generated from 
pRRSl3 would code the protein composed of the carboxy terminal 
656 amino acid residues of the skeletal muscle ryanodine receptor. 
CHO cells grown in alpha-modified MEM supplemented with 10% 
calf serum were transfected with PvuI-cleaved pRRSl3 [22]. Clones 
Cl3224 and Cl3238 were isolated by screening G418-resistant clones 
by RNA blotting analysis. 
A Wis:ar rat was repeatedly immunized with the purified rabbit 
skeletal muscle ryanodine receptor [3] and polyclonal antibody was 
partially purified by ammonium sulfate fractionation from antiserum 
collected 12 days after booster injection. This antibody specifically 
recognized both native and denatured forms of the ryanodine receptor 
protein. For immunoblotting analysis, membrane preparations (100 
pg protein) from CHO clones were electrophoresed on an SDS-7% 
polyacrylamide gel and transferred to GVHP filter (Millipore) as de- 
scribed [23]. The filter was incubated with the polyclonal antibody 
against he ryanodine receptor (- 0.2 &ml) and then with [‘*‘I]anti- 
rat immunoglobulins (New England Nuclear). After washing, the filter 
106 
was subjected to autoradiography. A high molecular weight standard 
mixture (Sigma) was used as size marker. 
For immunohistochemical analysis, the transformed cells were fixed 
with 2% paraformaldehyde, 1% picric acid, 0.05% glutaraldehyde and 
0.15 M sodium phosphate buffer (pH 7.3) for 10-20 min at room 
temperature. Non-transfected CHO cells were similarly treated and 
served as controls for the subsequent immunohistochemical staining. 
Following rinsing with phosphate buffered saline (PBS), the polyclo- 
nal antibody (- 0.3 pg/ml) was incubated with cells for 1 h at room 
temperature. After washing with PBS, the cell preparations were incu- 
bated with biotinylated rabbit anti-rat IgG and avidin-biotinylated 
peroxidase complex (Vector Labs), and then reacted with diaminoben- 
zidine4HCl and hydrogen peroxide. For light microscopy, the im- 
munostained cells were washed with PBS, coverslipped with glycerine, 
and examined under bright-field illumination. For electron micros- 
copy, the immunostained cells were osmicated, dehydrated, and em- 
bedded in Epon, and serial ultrathin (silver-gold) sections were pre- 
pared from Epon blocks. 
3. RESULTS AND DISCUSSION 
3.1. IdentiJication of a brain-speciJic 2.4-kb RNA species 
As reported previously, the rabbit brain contains the 
cardiac and the brain ryanodine receptor mRNA [IO- 
121. To investigate whether the skeletal muscle ryan- 
odine receptor mRNA exists in brain, we performed 
RNA blot analysis using a set of the cDNA fragments 
as probes. Fig. 1A shows the result of the analysis using 
a probe derived from the 3’-terminal region of the skel- 
etal muscle ryanodine receptor cDNA. Skeletal muscle 
contains the skeletal muscle ryanodine receptor mRNA 
with an estimated size of - 16-kb as described previ- 
ously [3]. No hybridizable RNA species with a similar 
size could be detected in other tissues examined [12]. 
However, the brain contains a hybridizable RNA spe- 
cies with an estimated size of 2.4 kb, which could be 
enriched by oligo-dT affinity chromatography. This 
RNA species in the brain could not hybridize with 
probes derived from the S-terminal or middle portion 
of the skeletal muscle ryanodine receptor cDNA. 
Probes from the cardiac and the brain ryanodine recep- 
tor cDNA did not detect this RNA species [12]. These 
results indicate that the brain contains a poly-adenyl- 
ated 2.4-kb RNA which possesses a nucleotide sequence 
identical or highly homologous with that of 3’-terminal 
region of the skeletal muscle ryanodine receptor 
mRNA. As shown in Fig. lB, the contents of this RNA 
species do not differ dramatically between fetal and 
adult brain. 
3.2. Characterization of the 2.4-kb RNA in brain 
To further characterize the 2.4-kb RNA, we screened 
cDNA libraries derived from rabbit brain poly(A)’ 
RNA using a probe from the skeletal muscle ryanodine 
receptor cDNA, and obtained several clones. Restric- 
tion endonuclease analysis showed that all these clones 
yielded fragments common to those derived from the 
3’-terminal region of the skeletal muscle ryanodine re- 
ceptor cDNA. Sequence analysis showed that these 
Volume 322, number 2 
A 
12345 
Origin 
23.1 
9.4 
6.6 
4.4 
2.3 
2.0 
FEBSLE-ITERS May 1993 
B 
1 2 
Origin - 
9.49 - 
7.46- 
2.37 - 
1.35- 
Fig. 1. Autoradiogram of blot hybridization analysis of RNA from rabbit tissues with a cDNA probe for the 3’-terminal region of the skeletal muscle 
ryanodine receptor mRNA. (A) Total RNA from skeletal muscle (3 pug, lane 1) and 10 lug of poly(A)+ RNA from heart (lane 2), brain (lane 3) 
stomach (lane 4) and kidney (lane 5) were analysed as in section 2.1. All the tissues were derived from an adult rabbit. (B) 10 pg of poly(A)’ RNA 
from adult (lane 1) and fetal (3 to 5 days before birth) brain (lane 2) were analysed. The size markers (in kb) are indicated. 
clones carry parts of the sequence of the skeletal muscle 
ryanodine receptor cDNA. We also cloned rabbit 
genomic DNA corresponding to the 3’-terminal region 
of the skeletal muscle ryanodine receptor cDNA, and 
determined four exon-intron boundaries in the gene. 
These DNA cloning results are summarized in Fig. 2. 
The cDNA sequence with 2309 nucleotides (excluding 
the poly(dA) tract) was obtained from brain cDNA 
libraries and was shown to be identical to the partial 
sequence of the skeletal muscle ryanodine receptor 
cDNA, corresponding to the residues 12922 to 15230 
(see section 2.2.). Residue 12922 is assumed to be close 
to the start site of the brain mRNA, because (i) the 
predicted mRNA length of 2309 plus - 100 to - 150 
(the poly (A) tail) nucleotides agrees well with the ob- 
served length of 2.4-kb, and (ii) our recent cloning strat- 
egy using the primer extention method [3,1 I] can yield 
sequences close to the mRNA-cap sites. The genomic 
sequence corresponding to residues 12628 to 13434 of 
the cDNA is uninterrupted and represents an exon in 
the gene. The transcription start site of the 2.4-kb 
mRNA should be located in this exon, as otherwise a 
discrepancy in the size of the mRNA would occur. In- 
terestingly, this exon contains several copies of the se- 
quence GCGGCGGGC, and the sequence of more than 
250 nucleotides around residue 13000 is highly GC-rich, 
as shown in Fig. 2. It is an attractive hypothesis that 
these motif sequences and the GC-rich region might 
represent brain-specific promoter and enhancer ele- 
ments, respectively. It might be possible that there are 
several transcription initiation sites corresponding to 
each of the motif sequences. These DNA cloning results 
suggest that the brain 2.4-kb mRNA is capable of cod- 
ing a protein identical with the carboxy-terminal frag- 
ment of the ryanodine receptor molecule, and that the 
codon for Met4382 is the first ATG triplet in this mRNA. 
A recent study showed that the brain contains a small 
amount of the skeletal muscle type-ryanodine receptor 
with M, - 400 kDa [24]. This observation does not 
contradict our results since the brain might contain a 
tiny amount of the 16kb mRNA and its protein prod- 
uct derived from the skeletal muscle receptor gene. 
3.3. Expression of the 3’-terminal portion of the skeletal 
muscle ryanodine receptor cDNA 
To test whether the ATG triplet encoding Met4382 of
107 
Volume 322, number 2 FEBSLETTERS May 1993 
5’___ -l"PZCl'X4~GAGCATC~A~CCl'A~~~~TCA TGJXXGCCTCCCGCCGCA~ AmAemrGAGATcTcAGAGACC 12600 
FLELAESILEYFRPYLGRI EIMGASRRIERIYFEISET 4200 
AACCGCGCCCAGIGGGAGATGCCC AAGGAGICCAAGCGCCAGTTCA CTTCGA~CAAC GGCCGGTGAGC TTCTXGAGGAC 12720 
NRAQWEMPQVKES KRQFIFDVVNEGGEAEKMELFVSFCED 4240 
ACCA-lTTE%2?GCAGA’TCGC~AGA 'PcTccGAGcCCGAGGGCGA GCCCGAGGCCGXGAGGACGAGGGCATGGGCGA CG CCGCCGACZGCGCCGAGGAGGGC~ 12840 
TIFEMQIAAQISEPEGEP EADEDEGMGEAAAEGAEEGAAG 4280 
GCCAcXG5ZCC~CC~~GCGGC&GCTACCGC~ GCCGAGGGCGCGGCCCGCACGGII;GC G GGGC ClW?XCG(%GCGTGCGGCGTGCGG 12960 
AEGAAGTVAAGATARLAAAAARALRGLSYRSLRRRVRRLR 4320 
CGXTCAW-CGGCWm-m-- ~GcGGGcGcG~G%TGCGCCTGCTC%GGGCTCG 13080 
RLTAREAATALAALLWAVVARAGAAGAGAAAGALRLLWGS 4360 
c?cllraxxCa;c d 
sphl 
GccAAGAAGGn;AcGGT~A~~~~~C~~C~CCAGC~~~~~~~~C~ 13200 
LFGGGLVEGAKKVTVTELLAG*MPD PTSDEVHGEQPAGPGG 4400 
~~~~~ACGGCGArrJ\GGAGCPGGC~~A~~C~C~~C~ GAccaxA~~ ~CGlWXC 13320 
DADGAGEGEGEGDAAEGDGDEEVAGHEAGPGGAEGVVAVA 4440 
GACGCGGGCCCCTTCCGGCCCGAGGGC~~CA lGGGCGACACCACGCCGGCGGAACCGCCCACGCCCGAGGGC'TCCCCGATCClyXAGAGGA4 &T 1:;;; 
DGGPFRPEGAGGLGDMGDTTPAEPPTPEGSPILKRKLGVD 
JTGA G~~C~~C~~C~~~A~~A~~C~ GGA~CGGGGAGAAGGAGGAAGTCCCCGAGGCCCCACCAGAACCCCC~G 13560 
GEEEELVPEPEPEPEPEPEKADEENGEKEEVPEAPPEPPK 4520 
AAAGCC~CCTCACCTCCTGCAAAGAAGGAGGAAGCCG CTGGAAGTGCAGAGGGTGA T&A CTACCT'ZTCCCGGAACGGAACTTCTAC 13680 
KAPPSPPAKKEEAGGAGMEFWGEL EVQRVKFLNYLSRNFY 4560 
ACCCiXCWZ'lTCCITGCCCTC'ITC?TGGCG 'ITII;cCA?rAA~~CTGcTGI??TATAAGGTcpCA TGGAGGGCPCGGCAGCAGGGGACCTT; 
TLRFLALFLAFAINFILLFY_KVSDSPPGEDDMEGSAAGDL 
_GGGTCGGGcTCCGGC (Ml) l#XXCTCGAGAGGGGGA CGAGGACGA04ACATGGTATACTACTTCCTGGAGGAGAGCACG'XCTACA'lG%iG 
AGAGSGGGSGWGSGAGEEAEGDEDENMVYYFLEESTGYME 
13800 
4600 
13920 
4640 
CCCGCCCTG~TGCCTGAGCCTGCTGC ACACGCl'XXXXXTTCCTCTGCA'XA'I'X4%TACAACTGCCTCAAGGTGCCC ClXG‘lGATClTCAA~GAA~ACGAAAG 
PALWCLSLLHTLVAFLCIIGYNCLKVPLVIFKREKELARK 
(M2) 
CTQZAGl'll-GACCCGCCTGTACA'TCACAGAGCAGCCTGGGGA GAC ACGTGAAGGGCCAGTGGGAC~~CACGCCGTCTTTC CCCAGCAACTAC'XCZGACAAGTXGTC 
LEFDGLYITEQPGDDDVKGQWDRLVLNTPSFPSNYWDKFV 
14040 
4680 
14160 
4720 
AAGCGGAAGGPCClGGACA&ACACGGCGACA T XCWXCGGGAGCGGAl'IGCCGAGC%X%GC ATGGACCTGGCCTC GCXGAGPTCACGGCCCACAAC r+GClx~ccGAcccc 14280 
KRKVLDKHGDIFGRERIAELLGMDLASLEITAHNERKPDP 4760 
_K lGGC-iCAXXCCA?CGA?I;TCAAGTACCAGATCTGGAAG~ TC'ITCACGGACX+CT'XTTCCTGTACC%GGC%GTACATGGTG4%XCCCTC 14400 
PPGLLTWLMSIDVKYQIWKFGVI FTDNSFLYLGWYMVMSL 4800 
CpGcGccACAACAACT~~C~~ACC' 
LGHYNNFFFAAHLLDIAMGVKTLRTI LSiVTHNGKDLVMT 
14520 
4840 
G'lTXGCCTr-CGTCG TACcTGTA~~TGGCcTTTAAc'ITcTpccGcAAG 
VGLLAVVVYLYTVVAFNF'ZRKFYNKSEDEDEPDMKCDDMM 
(M3) 
ACGXCTACCXTI'CCACATGTAC GTGGGCGTcCaGC ~~~GGGGACGAC4TC04GGACCCAGCGGG 
TC YL F HM YVGVRAGGG I G D E I ED PAG DEY ELY RVVF DITF 
?TCI?CTTCG'TCAlTG'XA?rCTGCPGGC CATCATCCAGGGIT?~~~~CC~~C~~A~~G~~~TA~CC~~~ 
FFFVIVILLAIIOGLIIDAFGELRDQQEQVKEDMETKCFI I..., 
14640 
4880 
14760 
4920 
14880 
4960 
iM4) 
XCYXGATlGGCAGTGACTAC'lTCGATACCACGCCCXACGGCTTC AGAC CACACGCTAGAGGAGCACAATCI'GGC CAA'fl'ACA~'ITC~TTGATGTATCPGATAAACAAGGA caG 15000 
CGIGSDYFDTTPHGFETHTLEEHNLANYMFFLMYLINKDE 5000 
ACGGAGCACACGGGCCAGGAGTCCTACGX TWiXUXTGTA'TCAGGAGA~ CrrCITCccCGCcGGCGA ClGClT CGCAAGCAGTACGCAGClGAGCXAGA CGCC 15120 
TEHTGQESYVWKMYQERCWDFFPAGDCFRKQYEDQLS~~~ 5037 
.%¶I 
CC~CCICCACCCCACC'TCCAGTGCCTTCXCTC ACAGCAAGCCC'TfXAGAC'ICCCG4%CAGAGGGATT'CCGAACCCGAGAAATAAAAGTCTGTTC CACC CCPGG-----3' 15230 
Fig. 2. Nucleotide sequence of 3’-terminal region of the rabbit skeletahmuscle ryanodine receptor cDNA and the deduced amino acid sequence. 
The sequence data have been taken from [3]. Numbers of nucleotide and amino acid residues are given at the right of each individual ine. Nucleotide 
residue 15230 is followed by a poly(dA) tract. The 5’-terminal residue of the sequence carried by each cDNA clone from brain libraries is indicated 
by filled circle (see section 2.2); the marks for the cDNA clones IBRRZ, 3,4,6,313 and 319 are omitted. The boundaries where the cDNA sequence 
is interrupted by introns in genomic DNA are shown by arrows; four exon-intron boundaries were determined in this study. Met4382 is marked 
with an asterisk and sequences of the GCGGCGGGC motif are underlined. Restriction endonuclease sites used in this study are given. The putative 
transmembrane segments (Ml-M4) of the ryanodine receptor are also indicated. 
the skeletal muscle ryanodine receptor functions as a After transfection, G418-resistant clones were selected 
translation initiation codon, CHO cells were transfected and then clones Cl3224 and C13238, expressing RNA 
with an expression plasmid, pRRS13. This plasmid car- species with the size expected from the expression con- 
ries the cDNA encoding the carboxy-terminal 656 struct, were obtained. Immunoblot analysis using poly- 
amino acid residues of the skeletal muscle ryanodine clonal antibody to the skeletal muscle ryanodine receg- 
receptor (if the protein translation would start from tor indicated that the transformed clones produced a 
Met4382) and the neomycin-resistance marker gene. membrane-associated protein with a relative molecular 
108 
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Fig. 3. Immunoblot analysis of the expressed protein in the pRRSl3 
transfected CHO clones. Membrane preparations (100 pg protein) 
from C7311 cells (lane l), Cl3224 cells (lane 2), Cl3238 cells (lane 3) 
and non-transfected CHO cells (lane 4) were analysed using a polyclo- 
nal antibody against he skeletal muscle ryanodine receptor. The clone 
C7311 expressing the skeletal muscle ryanodine receptor was obtained 
previously [3]. In lane 1 the largest band (- 400 kDa) shows the intact 
ryanodine receptor and other bands (- 300 and - 80 kDa) are 
thought to be cleaved products from the intact receptor. The size 
markers (in kDa) are given. 
mass (M,) of 75 kDa as in Fig. 3, in reasonable agree- 
ment with the M, of 73.0 kDa calculated from the amino 
acid sequence under the assumption that the translation 
starts from Met43*2. This result indicates that the ATG 
triplet for Met4382 functions as the initiating methionine 
codon in CHO cells. The nucleotide sequence surround- 
ing this ATG triplet agrees reasonably well with the 
consensus equence for initiation codons [25]. 
Next we analysed the subcellular localization of the 
expressed protein using the immunoperoxidase method. 
As shown in Fig. 4A, positive immunostaining was ob- 
tained in pRRS13-transformed cells. Light microscopic 
observation of the cells revealed immunopositive pre- 
cipitates in their perikaryal space adjacent o the nuclear 
membrane, whereas such immunolabel was far less vis- 
ible in the peripheral portions or virtually absent at the 
cell surface. The immunoelectron micrograph in Fig. 4B 
shows that the perikarya of the transformed cell contain 
highly electron-dense particles representing the im- 
munopositive material. Among cytoplasmic organelles, 
Fig. 4. Staining of pRRS13-transformed CHO cells with antibody 
against he skeletal muscle ryanodine receptor. (A) Photomicrograph 
of immunoperoxidase staining of Cl3238 cell, showing the expressed 
protein as black precipitates in the perikaryal space near the nucleus 
(n). Essentially the same results were also obtained in Cl3224 cells. 
Non-transfected CHO cells did not show any staining. (B) Immunoe- 
lectron microscopic profile of Cl3238 cell, showing the expressed 
protein as electron-dense particles in the perikaryal space. Note that 
the surfaces of endoplasmic reticulum and also those of cytoplasmic 
vacuoles are frequently outlined by the particles. Scale bars: 20 pm 
(A), 1 w @I. 
the ER was most commonly delineated by these parti- 
cles. Vacuoles of various size were also outlined by these 
particles. Thus the surfaces of the ER are among the 
sites of expression of the protein. These observations 
suggest that ER membrane sorting signals of the ryan- 
odine receptor molecule are in its carboxyl-terminal re- 
gion. However, measurable [3H]ryanodine binding or 
Ca” release in response to caffeine could not be de- 
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Fig. 5. Proposed scheme for the expression of the skeletal muscle ryanodine receptor gene. Molecular architecture of the ryanodine receptor is shown 
schematically according to our previous model [3]. 
tected in these transformed clones (unpublished obser- 
vation), in contrast to the CHO clones transfected with 
the full length skeletal muscle ryanodine receptor 
cDNA [3,4]. 
According to our molecular model of the ryanodine 
receptor [3], this expressed protein has the channel re- 
gion containing four putative transmembrane segments 
(Ml-M4), but lacks the ‘foot’ region. Furthermore this 
protein is thought o hold the region around amino acid 
residue 4500 which is suggested to be involved in Ca2’ 
binding and calcium-induced calcium release in the skel- 
etal muscle ryanodine receptor [26,27]. A possible 
scheme for the expression of the skeletal muscle ryan- 
odine receptor gene is shown in Fig. 5. The possibility 
might arise that this protein forms homo- or hetero- 
tetramers contributing a variety of calcium release 
channels in the brain. 
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